Chelidonium Combination Liquid
NDC 63083-9217
Product Information
Chelidonium Combination is a UNAPPROVED HOMEOPATHIC-approved product labeled by Professional Complementary Health Formulas. This medication is typically used as a allergens [cs]. It is supplied as a liquid for oral administration. This product entry covers the primary NDC 63083-9217 and its associated package configuration. This profile includes active and inactive ingredient UNII references and FDA labeling data.
Primary Identification
Clinical Specifications
Labeler & Regulatory Data
Marketing Timeline
Code Structure Chart
Product Details
What is NDC 63083-9217?
What are the uses of this product?
What are Active Ingredients of this product?
Which are the associated UNII Codes?
The UNII codes for the active ingredients in this product are:
- AMARYLLIS BELLADONNA WHOLE (UNII: 11B89M58UN)
- AMARYLLIS BELLADONNA WHOLE (UNII: 11B89M58UN) (Active Moiety)
- CHELIDONIUM MAJUS WHOLE (UNII: 7E889U5RNN)
- CHELIDONIUM MAJUS WHOLE (UNII: 7E889U5RNN) (Active Moiety)
- ARTICHOKE (UNII: 4F3W47PLBE)
- ARTICHOKE (UNII: 4F3W47PLBE) (Active Moiety)
- BOS TAURUS BILE (UNII: ET3651ZLOU)
- BOS TAURUS BILE (UNII: ET3651ZLOU) (Active Moiety)
Which are the Inactive Ingredients associated UNII Codes?
The inactive ingredients are all the component of a medicinal product OTHER than the active ingredient(s). The acronym "UNII" stands for “Unique Ingredient Identifier” and is used to identify each inactive ingredient present in a product. The UNII codes for the inactive ingredients in this product are:
- ALCOHOL (UNII: 3K9958V90M)
- WATER (UNII: 059QF0KO0R)
Which are the Pharmacologic Classes of this product?
- Allergens - [CS]
- Cell-mediated Immunity - [PE] (Physiologic Effect)
- Dietary Proteins - [CS]
- Increased Histamine Release - [PE] (Physiologic Effect)
- Non-Standardized Food Allergenic Extract - [EPC] (Established Pharmacologic Class)
- Non-Standardized Plant Allergenic Extract - [EPC] (Established Pharmacologic Class)
- Plant Proteins - [CS]
- Vegetable Proteins - [CS]
* Please review the full disclaimer at the bottom of this page.